On May 20, 2020, Diffusion Pharmaceuticals announced it had entered into an agreement with the Romanian National Institute…
On May 19, 2020, CytoDyn announced it will be coordinating with the National Institution of Health of Mexico…
On May 18, 2020, an investigational long-acting form of the HIV drug cabotegravir injected once every 8 weeks…
On May 18, 2020, with $9 million from the COVID-19 Therapeutics Accelerator, an international group of physicians and…
On May 15, 2020, the California Institute for Regenerative Medicine (CIRM) board approved new clinical trials for COVID-19…
On May 14, 2020, the National Institute of Allergy and Infectious Diseases (NIAID) announced that a clinical trial…
On May 13, 2020, Immunic announced it had received first regulatory approval from Germany’s BfArM to initiate a…
On May 12, 2020, the National Research Council of Canada (NRC) announced a collaboration with CanSino Biologics to…
On May 11, 2020, the FDA announced actions to accelerate the development of prevention and treatment options for…
On May 11, 2020, Arbutus Biopharma announced the establishment of a new research initiative focused on the identification…
On May 8, 2020, the NIH announced that a randomized, controlled clinical trial evaluating the safety and efficacy…
On May 7, 2020, Catalent announced Phase 3 study for lenzilumab, the companyï¾’s proprietary Humaneeredï¾® anti-human granulocyte macrophage-colony…
On May 6, 2020, Predictive Oncology announced the acquisition of Soluble Therapeutics and partnership and licensing of a…
On May 5, 2020, the HonorHealth Research Institute and HonorHealth announced the successful enrollment on a novel combination…
On May 5, 2020, Organicell Regenerative Medicine announced the FDA has approved the Investigational New Drug application for…
On May 5, 2020, Pfizer and BioNTech announced the first participants have been dosed in the U.S. in…
On May 1, 2020, the FDA issued an Emergency Use Authorization (EUA) for the investigational antiviral drug remdesivir…
On May 1, 2020, the U.S. Dept. of Veterans Affairs (VA) announced participation in a series of clinical…
On Apr. 29, 2020, the National Institutes of Health (NIH) announced that hospitalized patients with advanced COVID-19 and…
On Apr. 29, 2020, an anti-inflammatory drug developed at Scripps Research 25 years ago tested as a way…
On Apr. 29, 2020, Emory University played a leading role in the government-sponsored clinical trial of the COVID-19…
On Apr. 29, 2020, researchers at Montefiore Health System and Albert Einstein College of Medicine and NYU Langone…
On Apr. 29, 2020, researchers at Montefiore Health System and Albert Einstein College of Medicine announced that they…
On Apr. 29, 2020, a team of Texas A&M University researchers asked hundreds of frontline medical workers to…
On Apr. 28, 2020, INOVIO announced that its Phase 1 U.S. clinical trial for COVID-19 DNA vaccine INO-4800…
On Apr. 24, 2020, BioSig Technologies announced that subsidiary ViralClear had submitted an Investigational New Drug (IND) application…
On Apr. 23, 2020, Yale researchers began a clinical trial at Yale New Haven Hospital to test the…
On Apr. 20, 2020, SNBL announced their intention to participate in the development of a prophylactic DNA vaccine…
On Apr. 22, 2020, BioNTech and Pfizer announced that the German regulatory authority, the Paul-Ehrlich-Institut, has approved the…
On Apr. 21, 2020, Rutgers University announced it has launched the nation’s largest prospective study of health care…